Selected research
Industry Growth & Trends
Global Antiemetics Industry Growth and Trends Forecast to 2032
Market perspective
The global Antiemetics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Antiemetics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Antiemetics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Antiemetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Antiemetics include Johnson & Johnson, Merck, Eli Lilly, Pfizer, GlaxoSmithKline, Baxter, Sanofi Aventis, Bristol Myers Squibb and Astellas, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Antiemetics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Antiemetics market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antiemetics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antiemetics.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Antiemetics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Antiemetics Market by Company
Johnson & Johnson
Merck
Eli Lilly
Pfizer
GlaxoSmithKline
Baxter
Sanofi Aventis
Bristol Myers Squibb
Astellas
Antiemetics Segment by Type
Steroids
Antihistamines (H1 histamine receptor antagonists)
Anticholinergics
Dopamine antagonists
Cannabinoids
Benzodiazepines
NK1 receptor antagonist
5-HT3 receptor antagonists
Others
Antiemetics Segment by Application
Retail Pharmacy
Online Pharmacy
Hospital Pharmacy
Others
Antiemetics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiemetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antiemetics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiemetics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiemetics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Antiemetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Steroids
- Antihistamines (H1 histamine receptor antagonists)
- Anticholinergics
- Dopamine antagonists
- Cannabinoids
- Benzodiazepines
- NK1 receptor antagonist
- 5-HT3 receptor antagonists
- Others
Applications
- Retail Pharmacy
- Online Pharmacy
- Hospital Pharmacy
- Others
Companies covered
- Johnson & Johnson
- Merck
- Eli Lilly
- Pfizer
- GlaxoSmithKline
- Baxter
- Sanofi Aventis
- Bristol Myers Squibb
- Astellas
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Antiemetics Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Antiemetics Sales Estimates and Forecasts (2021-2032)
- 1.3 Antiemetics Market by Type
- 1.3.1 Steroids
- 1.3.2 Antihistamines (H1 histamine receptor antagonists)
- 1.3.3 Anticholinergics
- 1.3.4 Dopamine antagonists
- 1.3.5 Cannabinoids
- 1.3.6 Benzodiazepines
- 1.3.7 NK1 receptor antagonist
- 1.3.8 5-HT3 receptor antagonists
- 1.3.9 Others
- 1.4 Global Antiemetics Market Size by Type
- 1.4.1 Global Antiemetics Market Size Overview by Type (2021-2032)
- 1.4.2 Global Antiemetics Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Antiemetics Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Antiemetics Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Antiemetics Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Antiemetics Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Antiemetics Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Antiemetics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Antiemetics Industry Trends
- 2.2 Antiemetics Industry Drivers
- 2.3 Antiemetics Industry Opportunities and Challenges
- 2.4 Antiemetics Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Antiemetics Revenue (2021-2026)
- 3.2 Global Top Players by Antiemetics Sales (2021-2026)
- 3.3 Global Top Players by Antiemetics Price (2021-2026)
- 3.4 Global Antiemetics Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Antiemetics Major Company Production Sites & Headquarters
- 3.6 Global Antiemetics Company, Product Type & Application
- 3.7 Global Antiemetics Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Antiemetics Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Antiemetics Players Market Share by Revenue in 2025
- 3.8.3 2025 Antiemetics Tier 1, Tier 2, and Tier 3
4 Antiemetics Regional Status and Outlook
- 4.1 Global Antiemetics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Antiemetics Historic Market Size by Region
- 4.2.1 Global Antiemetics Sales in Volume by Region (2021-2026)
- 4.2.2 Global Antiemetics Sales in Value by Region (2021-2026)
- 4.2.3 Global Antiemetics Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Antiemetics Forecasted Market Size by Region
- 4.3.1 Global Antiemetics Sales in Volume by Region (2027-2032)
- 4.3.2 Global Antiemetics Sales in Value by Region (2027-2032)
- 4.3.3 Global Antiemetics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antiemetics by Application
- 5.1 Antiemetics Market by Application
- 5.1.1 Retail Pharmacy
- 5.1.2 Online Pharmacy
- 5.1.3 Hospital Pharmacy
- 5.1.4 Others
- 5.2 Global Antiemetics Market Size by Application
- 5.2.1 Global Antiemetics Market Size Overview by Application (2021-2032)
- 5.2.2 Global Antiemetics Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Antiemetics Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Antiemetics Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Antiemetics Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Antiemetics Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Antiemetics Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Antiemetics Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Johnson & Johnson
- 6.1.1 Johnson & Johnson Company Information
- 6.1.2 Johnson & Johnson Business Overview
- 6.1.3 Johnson & Johnson Antiemetics Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Johnson & Johnson Antiemetics Product Portfolio
- 6.1.5 Johnson & Johnson Recent Developments
- 6.2 Merck
- 6.2.1 Merck Company Information
- 6.2.2 Merck Business Overview
- 6.2.3 Merck Antiemetics Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Merck Antiemetics Product Portfolio
- 6.2.5 Merck Recent Developments
- 6.3 Eli Lilly
- 6.3.1 Eli Lilly Company Information
- 6.3.2 Eli Lilly Business Overview
- 6.3.3 Eli Lilly Antiemetics Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Eli Lilly Antiemetics Product Portfolio
- 6.3.5 Eli Lilly Recent Developments
- 6.4 Pfizer
- 6.4.1 Pfizer Company Information
- 6.4.2 Pfizer Business Overview
- 6.4.3 Pfizer Antiemetics Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Pfizer Antiemetics Product Portfolio
- 6.4.5 Pfizer Recent Developments
- 6.5 GlaxoSmithKline
- 6.5.1 GlaxoSmithKline Company Information
- 6.5.2 GlaxoSmithKline Business Overview
- 6.5.3 GlaxoSmithKline Antiemetics Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 GlaxoSmithKline Antiemetics Product Portfolio
- 6.5.5 GlaxoSmithKline Recent Developments
- 6.6 Baxter
- 6.6.1 Baxter Company Information
- 6.6.2 Baxter Business Overview
- 6.6.3 Baxter Antiemetics Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Baxter Antiemetics Product Portfolio
- 6.6.5 Baxter Recent Developments
- 6.7 Sanofi Aventis
- 6.7.1 Sanofi Aventis Company Information
- 6.7.2 Sanofi Aventis Business Overview
- 6.7.3 Sanofi Aventis Antiemetics Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Sanofi Aventis Antiemetics Product Portfolio
- 6.7.5 Sanofi Aventis Recent Developments
- 6.8 Bristol Myers Squibb
- 6.8.1 Bristol Myers Squibb Company Information
- 6.8.2 Bristol Myers Squibb Business Overview
- 6.8.3 Bristol Myers Squibb Antiemetics Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Bristol Myers Squibb Antiemetics Product Portfolio
- 6.8.5 Bristol Myers Squibb Recent Developments
- 6.9 Astellas
- 6.9.1 Astellas Company Information
- 6.9.2 Astellas Business Overview
- 6.9.3 Astellas Antiemetics Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Astellas Antiemetics Product Portfolio
- 6.9.5 Astellas Recent Developments
7 North America by Country
- 7.1 North America Antiemetics Sales by Country
- 7.1.1 North America Antiemetics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Antiemetics Sales by Country (2021-2026)
- 7.1.3 North America Antiemetics Sales Forecast by Country (2027-2032)
- 7.2 North America Antiemetics Market Size by Country
- 7.2.1 North America Antiemetics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Antiemetics Market Size by Country (2021-2026)
- 7.2.3 North America Antiemetics Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Antiemetics Sales by Country
- 8.1.1 Europe Antiemetics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Antiemetics Sales by Country (2021-2026)
- 8.1.3 Europe Antiemetics Sales Forecast by Country (2027-2032)
- 8.2 Europe Antiemetics Market Size by Country
- 8.2.1 Europe Antiemetics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Antiemetics Market Size by Country (2021-2026)
- 8.2.3 Europe Antiemetics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Antiemetics Sales by Country
- 9.1.1 Asia-Pacific Antiemetics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Antiemetics Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Antiemetics Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Antiemetics Market Size by Country
- 9.2.1 Asia-Pacific Antiemetics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Antiemetics Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Antiemetics Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Antiemetics Sales by Country
- 10.1.1 South America Antiemetics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Antiemetics Sales by Country (2021-2026)
- 10.1.3 South America Antiemetics Sales Forecast by Country (2027-2032)
- 10.2 South America Antiemetics Market Size by Country
- 10.2.1 South America Antiemetics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Antiemetics Market Size by Country (2021-2026)
- 10.2.3 South America Antiemetics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Antiemetics Sales by Country
- 11.1.1 Middle East and Africa Antiemetics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Antiemetics Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Antiemetics Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Antiemetics Market Size by Country
- 11.2.1 Middle East and Africa Antiemetics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Antiemetics Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Antiemetics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Antiemetics Value Chain Analysis
- 12.1.1 Antiemetics Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Antiemetics Production Mode & Process
- 12.2 Antiemetics Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Antiemetics Distributors
- 12.2.3 Antiemetics Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst